Venture capital
France
Last Deal May 2026

Andera Partners

Investment focus

Sectors

From firm website, not verified

Investment Stages

From firm website, not verified

Geographic Focus

Europe
United States
Global

Investment thesis

Formerly Edmond de Rothschild Investment Partners. Paris-based life sciences VC backing innovative therapeutics and medical technology companies from early through late stage across Europe and the US.

Typical check size

€15M – €60M

How To Pitch Andera Partners

No Stated Policy
Andera Partners hasn't published an outreach policy. A short, specific cold email is the safest default.
Source

Recent Deals

Auto-extracted from press releases.

Round-Size Sweet Spot

From 7 recent deals

P25

€27M

Median

€62M

P75

€149M

Stated range: €15M – €60M

Portfolio highlights

Amolyt Pharma - rare endocrine disease biotech acquired by AstraZeneca for $1.05B
ReViral - UK RSV antiviral biotech acquired by Pfizer (2022)
Corvidia Therapeutics - cardiovascular disease biotech acquired by Novo Nordisk

Website reachable as of Aug 2026. Focus and check size as listed by the firm, not independently verified.

Ready To Reach Andera Partners?

A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.